This statutory measure has enabled Canadian pharmaceutical manufacturers to apply for a compulsory licence to export a lower-cost, generic version of patented pharmaceutical products to developing or least-developed countries that are unable to manufacture their own.
这一法律措施使得加拿大制药商可申请强制许可证，向发展中或最不发达国家出口它们不能自己制造的低价、非专利版的专利药品。